UBE2M and lung cancer: By using two available Affymetrix microarray datasets [135, 136], Li et al. [87] identified that UBE2M, but not NAE1 and UBA3, is overexpressed in multiple types of lung cancers and associated with poor survival outcomes, as UBE2M can induce cell proliferation.